What Happened?
Cambridge, MA-based Seres Therapeutics Appointed David Ege as Chief Technology Officer
Date of management change: October 22, 2020
Cambridge, MA-based Seres Therapeutics Appointed David Ege as Chief Technology Officer
Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
David Ege is Chief Technology Officer at Seres Therapeutics. Previously, David held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Lee Jason, Phul Sy, Patton Gary, Webb Terry, Biolatto Anthony, Kracke Cameron, Stremler Jacob, Edwards Damon, Davidson Steven, Burke Thomas, Leonard Joe
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.